China Matches Neuralink with BCI Implants, Sets $902 Pricing for Procedures
Chinese companies CIBR and NeuCyber NeuroTech have completed three human brain-computer interface implants and plan to expand trials as they push for global leadership in the field.
- China's CIBR and NeuCyber NeuroTech have successfully implanted their Beinao No. 1 brain-computer interface chip in three human patients, matching Neuralink's progress.
- The Beinao No. 1 chip enables paralyzed patients to control robotic arms and computers, and has demonstrated speech decoding for an ALS patient with a speech disorder.
- China has introduced pricing guidelines for BCI procedures, with invasive implants costing approximately $902 per procedure, signaling a move toward commercialization.
- CIBR and NeuCyber aim to implant the Beinao No. 1 chip in 13 patients by the end of 2025 and are developing a more invasive Beinao No. 2 chip for future trials.
- China is working to establish global standards for brain-computer interface technology to compete with U.S.-based Neuralink and other industry leaders.